Skip Navigation

Morgan Stanley upgrades Sarepta Therapeutics, says biotech stock can rally more than 50%

Published Wed, Mar 1 20237:07 AM ESTUpdated Wed, Mar 1 20239:20 AM EST

Hakyung Kim @hakyungkim_

More In Analyst Calls

Forget Nvidia. Here are 5 undervalued tech stocks every investor should own, Goldman Sachs says

Forget Nvidia. Here are 5 undervalued tech stocks every investor should own, Goldman Sachs says

Michael Bloom2 hours ago

FanDuel parent Flutter joining the big leagues. Moving primary listing to U.S. from U.K. may spur investor interest

FanDuel parent Flutter joining the big leagues. Moving primary listing to U.S. from U.K. may spur investor interest

Barclays upgrades a little-known biotech stock that it says can more than double

Barclays upgrades a little-known biotech stock that it says can more than double